Market revenue in 2024 | USD 15.8 million |
Market revenue in 2030 | USD 19.7 million |
Growth rate | 3.7% (CAGR from 2025 to 2030) |
Largest segment | Lovaza |
Fastest growing segment | Lovaza |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Vascepa, Lovaza |
Key market players worldwide | Woodward Pharma Services, Mankind Pharma, CSPC Pharmaceutical Group Ltd, Sofgen Pharmaceuticals, Wilshire Pharmaceuticals, Sun Pharmaceutical Industries, PuraCap Pharmaceutical, Chartwell Pharmaceuticals, Amneal Pharmaceuticals Inc Ordinary Shares - Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account